Search

Subject 616.9940095

1738. What is the value of third‐line chemotherapy in advanced gastroesophageal cancer? A 5‐year retrospective analysis at a single center. Issue 1 (17th November 2019)

Authors:
Lam, Justina Yick Ching; Choo, Su Pin; Tai, David Wai‐Meng; Tan, Iain Bee Huat; Tham, Chee Kian; Koo, Wen Hsin; Ong, Simon Yew Kuang; Ang, Soo Fan; Chua, Clarinda Wei Ling; Chong, Dawn Qingqing; Teo, Patrick Tze Hern; Lee, Christabel Jing Zhi; Ee, Samuel Cheng En; Ng, Matthew Chau Hsien
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 16:Issue 1(2020)
Page Start:
23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

1739. When compared to plasma‐based detection, osimertinib‐treated non‐small cell lung cancer (NSCLC) with tissue rebiopsy‐confirmed acquired T790M mutation is associated with better survival. Issue 2 (4th December 2019)

Authors:
Kwok, Wang Chun; Ho, James Chung Man; Lam, David Chi Leung; Lui, Macy Mei Sze; Ip, Mary Sau Man; Tam, Terence Chi Chun
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 17:Issue 2(2021)
Page Start:
e35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗